Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of botulinum toxin type A for treating frown lines
IRCT20150101020514N8Phase 3Completed
- Sponsor
- Imen Vaccine Alborz
- Start
- Feb 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of botulinum toxin type A in rhytides, sponsored by Imen Vaccine Alborz. Started Feb 2019; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
rhytides
Beyond the preview
Go deeper on IRCT20150101020514N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150101020514N8.